Status:
WITHDRAWN
TC02 Obese Women Using It Morphine vs PCA IV Hydromorphone for Post-Cesarean Analgesia
Lead Sponsor:
Northwestern University
Conditions:
Pain, Postoperative
Obesity
Eligibility:
FEMALE
18-65 years
Phase:
PHASE4
Brief Summary
Cesarean deliveries are the most commonly performed surgery in the United States and account for 32.9% of all births.8,9 The ASA recommends the use of neuraxial opioids of post-cesarean analgesia part...
Eligibility Criteria
Inclusion
- Term (≥37 week's gestation)
- Healthy
- ASA class 2-3
- BMI ≥40kg/m2 scheduled for elective cesarean section whose anesthetic plan is for neuraxial anesthesia (spinal or combined-spinal epidural technique)
Exclusion
- Women with ASA \>3,
- BMI \<40 kg/m2
- Allergy to any of the medications used for pain control
- Contraindication to the spinal anesthetic technique
- Known sleep apnea or other sleep disordered breathing
- Regular use of other medications that cause respiratory depression (ie. benzodiazepines).
Key Trial Info
Start Date :
August 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2021
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03282669
Start Date
August 1 2019
End Date
December 1 2021
Last Update
May 6 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.